N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142228 |
| CAS No | NA |
| Mol.F. | C9H19N3O4 |
| Mol.Wt. | 233.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142229 |
| CAS No | NA |
| Mol.F. | C17H19N3OS |
| Mol.Wt. | 313.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142230 |
| CAS No | NA |
| Mol.F. | C17H19N3O2S |
| Mol.Wt. | 329.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142231 |
| CAS No | NA |
| Mol.F. | C29H26N4OS2 |
| Mol.Wt. | 510.67 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142232 |
| CAS No | NA |
| Mol.F. | C6H5N7O2 |
| Mol.Wt. | 207.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142233 |
| CAS No | NA |
| Mol.F. | C6H8N4O3 |
| Mol.Wt. | 184.16 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142234 |
| CAS No | NA |
| Mol.F. | C7H8N4O4 |
| Mol.Wt. | 212.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142235 |
| CAS No | NA |
| Mol.F. | C12H13N5O5 |
| Mol.Wt. | 307.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142236 |
| CAS No | NA |
| Mol.F. | C8H7N7O3 |
| Mol.Wt. | 249.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142237 |
| CAS No | NA |
| Mol.F. | C8H7N7O3 |
| Mol.Wt. | 249.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142238 |
| CAS No | NA |
| Mol.F. | C5H5N5O3 |
| Mol.Wt. | 183.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142239 |
| CAS No | NA |
| Mol.F. | C4H5N5O2 |
| Mol.Wt. | 155.12 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142240 |
| CAS No | NA |
| Mol.F. | C16H15N5O2 |
| Mol.Wt. | 309.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142241 |
| CAS No | NA |
| Mol.F. | C17H17N5O3 |
| Mol.Wt. | 339.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142242 |
| CAS No | NA |
| Mol.F. | C12H11N3O2 |
| Mol.Wt. | 229.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142243 |
| CAS No | NA |
| Mol.F. | C11H9N3O2 |
| Mol.Wt. | 215.21g/mole |
| INV STATUS | CUSTOM SYNTHESIS |